Results 21 to 30 of about 145,187 (366)

Genome-wide and Mendelian randomisation studies of liver MRI yield insights into the pathogenesis of steatohepatitis [PDF]

, 2020
Background A non-invasive method to grade the severity of steatohepatitis and liver fibrosis is magnetic resonance imaging (MRI) based corrected T1 (cT1).
Banerjee, R, Banerjee, R, Bell, J.D., Bell, J.D., Hemingway, H., Hemingway, H., Hingorani, A.D., Hingorani, A.D., Kelly, M., Kelly, M., McGonigle, J., McGonigle, J., Neubauer, S., Neubauer, S., Nicholls, R.C., Nicholls, R.C., Parisinos, C.A., Parisinos, C.A., Patel, R.S., Patel, R.S., Thomas, E.L., Thomas, E.L., Wilman, H., Wilman, H., Yaghootkar, H., Yaghootkar, H.   +25 more
core   +3 more sources

Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis

Clinical and Molecular Hepatology, 2022
The initial presentation of non-alcoholic steatohepatitis (NASH) is hepatic steatosis. The dysfunction of lipid metabolism within hepatocytes caused by genetic factors, diet, and insulin resistance causes lipid accumulation.
Kuei-Chuan Lee, Pei-Shan Wu, Han‐Chieh Lin   +2 more
semanticscholar   +1 more source

The effect of 12 weeks regular physical activity and vitamin E in the treatment of non-alcoholic steatohepatitis: A pilot study [PDF]

, 2015
Background: Despite the prevalence of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), there was no treatment has been proven to be effective in these common diseases.
Eslami, L., Eslami, L., Isazadehfar, K., Karami, M., Nakhostinroohi, B., Rahmani-nia, F.   +5 more
core   +7 more sources

The Effects of Probiotics, Prebiotics and Synbiotics in Non-Alcoholic Fat Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH): A Systematic Review

International Journal of Molecular Sciences, 2022
Modifications in the microbiota caused by environmental and genetic reasons can unbalance the intestinal homeostasis, deregulating the host’s metabolism and immune system, intensifying the risk factors for the development and aggravation of non-alcoholic
Rodrigo Zamignan Carpi, S. Barbalho, K. P. Sloan, LUCAS FORNARI LAURINDO, H. Gonzaga, P. C. Grippa, T. L. M. Zutin, R. J. Girio, C. Repetti, C. R. P. Detregiachi, P. C. S. Bueno, Eliana de Souza Bastos Mazuqueli Pereira, R. Goulart, J. Haber   +13 more
semanticscholar   +1 more source

Burden of non-alcoholic steatohepatitis among children with type 2 diabetes mellitus

Diabetology & Metabolic Syndrome, 2021
This claims-based retrospective cohort study examined the prevalence and incremental impact of non-alcoholic steatohepatitis among children with type 2 diabetes mellitus in the United States.
Lauren Parlett, Qinli Ma, Qian Shi, Geoffrey Crawford, Laura Herrera Scott, Vincent Willey, Abiy Agiro   +6 more
doaj   +1 more source

From Non-Alcoholic Steatohepatitis (NASH) to Hepatocellular Carcinoma (HCC): Epidemiology, Incidence, Predictions, Risk Factors, and Prevention

Cancers, 2023
Simple Summary Non-alcoholic fatty liver disease affects up to a quarter of the adult population in many developed and developing countries. This disease has become the fastest-growing cause of hepatocellular carcinoma (HCC) in industrialized countries ...
B. Motta, M. Masarone, P. Torre, Marcello Persico   +3 more
semanticscholar   +1 more source

IMAGING DIAGNOSIS OF NONALCOHOLIC STEATOHEPATITIS [PDF]

Romanian Medical Journal, 2018
Non-alcoholic fatty liver comprises several clinical entities, starting from hepatic steatosis and reaching steatohepatitis, fibrosis and liver cirrhosis; it is currently considered a major public health issue.
Anca Smaranda Farmazon, Alexandru Radu Mihailovici, Rodica Diaconu, Daniela Carmen Neagoe, Gabriel Nicolae Ianosi, Oana Sorina Tica, Maria Aurelia Buse   +6 more
doaj   +1 more source

European Bilberry Extract Ameliorates Dietary Advanced Glycation End Products-Induced Non-Alcoholic Steatohepatitis in Rats via Gut Microbiota and Its Metabolites. [PDF]

Nutrients
Shen L, Cheng R, Chen W, Liu H, Wang X, He R, Mo X, Liu L.   +7 more
europepmc   +2 more sources

A metagenomic study identifies a Prevotella copri enriched microbial profile associated with non‐alcoholic steatohepatitis in subjects with obesity

Journal of Gastroenterology and Hepatology, 2023
Non‐alcoholic fatty liver disease (NAFLD) is the most common cause of liver disease. Increasing evidence indicates that the gut microbiota can play an important role in the pathophysiology of NAFLD.
S. Morán-Ramos, D. Cerqueda-García, B. López-Contreras, Elena Larrieta‐Carrasco, H. Villamil-Ramírez, Selene Molina-Cruz, N. Torres, M. Sánchez-Tapia, R. Hernández-Pando, C. Aguilar-Salinas, T. Villarreal-Molina, S. Canizales-Quinteros   +11 more
semanticscholar   +1 more source

Correlation of serum aspartate aminotransferase level to platelet count ratio index with non-alcoholic fatty liver disease activity score

Bangabandhu Sheikh Mujib Medical University Journal, 2019
In case of non-alcoholic fatty liver disease, the ratio of serum aspartate  aminotransferase (AST) level to platelet count index has been proposed as a non-invasive and readily available tool for the assessment of non-alcoholic steatohepatitis. The study
Dulal Chandra Das, Shahinul Alam, Sheikh Mohammad Noor-E-Alam, Mohammed Kamal, Forhadul H. Mollah, . Mamun-Al-Mahtab   +5 more
doaj   +1 more source